Managing a locally advanced malignant thymoma complicated by nephrotic syndrome: A case report

Journal of Medical Case Reports

Volumn 2, Issue , 2008, Pages

  Teoh, Daren C Y ^a   El Modir, Ahmed ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; OMEPRAZOLE; PREDNISOLONE; PYRIDOSTIGMINE;

ADULT; ARTHRALGIA; ARTICLE; BURSITIS; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE CLEARANCE; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG TOLERABILITY; EPIGASTRIC PAIN; HISTOPATHOLOGY; HUMAN; INDIAN; MALE; MULTIPLE CYCLE TREATMENT; MYASTHENIA GRAVIS; NEPHROTIC SYNDROME; PATIENT REFERRAL; PLEURA BIOPSY; PRIORITY JOURNAL; THORACOTOMY; THYMECTOMY; THYMOMA; THYMUS CANCER; TREATMENT OUTCOME; TUMOR LOCALIZATION; VOMITING;

EID: 45149127498     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-2-89     Document Type: Article

References (10)

1. Berruti A Borasio P Roncari A: Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in invasive thymomas. Ann Oncol 1993, 4:429-431. 8353078
2. Hosokawa T Maki H Saito T Harada M Isobe H: A giant invasive thymoma made respectable by cisplatin, vincristine, doxorubicin and eotposide. Gan To Kagaku Ryoho 1999, 26(5):697-701. 10234303
3. Hejna M Haberl I Raderer M: Nonsurgical management of malignant thymoma. Cancer 1999, 85:1871-84. 10223225
4. Johnson S Eng T Giaccone G Thomas C Jr: Thymoma: Update for the New Millenium. The Oncologist 2001, 6:239-246. 10.1634/theoncologist.6-3-239 11423670
5. Lasseur C Combe C Deminiere C Pellegrin J Aparicio M: Thymoma associated with myasthenia gravis and minimal lesion nephrotic syndrome. Am J Kidney Dis 1999, 33(5):e4. 10.1016/S0272-6386(99)70444-0 10213666
6. Hanna N Gharpure V Abonour R Cornetta K Loehrer P: High-dose carboplatin with etoposide in patients with recurrent thymoma: The Indiana University experience. Bone Marrow Transplant 2001, 28(5):435-8. 10.1038/ sj.bmt.1703181 11593315
7. Jan N Villani G Trambert J Fehmian C Sood B Wiernik P: A novel second line chemotherapy treatment of recurrent thymoma. Med Onc 1997, 14(3-4):163-8. 9468040
8. Macchiarini P Chella A Ducci F Rossi B Testi C Bevilacqua G Angeletti A: Neoadjuvant chemotherapy, surgery and postoperative radiation therapy for invasive thymoma. Cancer 1991, 68:706-13. 10.1002/ 1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H 1855170
9. Mak SK: Long-term outcome of adult-onset minimal-change nephropathy. Nephro-Dial-Transplant 1996, 11(11):2192-201. 8941578
10. Lokich J Anderson N: Carboplatin versue cisplatin in solid tumour: An analysis of the literature. Annal of Oncology 1998, 9(1):13-21. 10.1023/ A:1008215213739 9541678